FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,602,312 | -59.4% | 158,802 | -9.9% | 0.00% | -75.0% |
| Q3 2022 | $3,949,000 | +15.2% | 176,204 | +27.4% | 0.00% | +33.3% |
| Q2 2022 | $3,428,000 | -36.1% | 138,348 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $5,364,000 | -43.0% | 138,348 | -14.0% | 0.00% | -33.3% |
| Q4 2021 | $9,417,000 | -12.4% | 160,945 | -11.3% | 0.01% | -25.0% |
| Q3 2021 | $10,754,000 | -30.7% | 181,447 | +1.5% | 0.01% | -33.3% |
| Q2 2021 | $15,512,000 | +4.1% | 178,725 | -1.1% | 0.01% | +9.1% |
| Q1 2021 | $14,897,000 | -5.2% | 180,677 | +4.5% | 0.01% | -8.3% |
| Q4 2020 | $15,721,000 | +142.7% | 172,887 | +6.7% | 0.01% | +100.0% |
| Q3 2020 | $6,478,000 | +36.3% | 162,080 | +17.0% | 0.01% | +20.0% |
| Q2 2020 | $4,753,000 | +58.3% | 138,520 | +2.5% | 0.01% | +25.0% |
| Q1 2020 | $3,002,000 | +23.8% | 135,146 | +9.0% | 0.00% | +100.0% |
| Q4 2019 | $2,425,000 | +2.1% | 123,935 | -19.0% | 0.00% | 0.0% |
| Q3 2019 | $2,375,000 | +94.0% | 152,914 | +153.6% | 0.00% | +100.0% |
| Q2 2019 | $1,224,000 | +27.1% | 60,286 | +10.0% | 0.00% | 0.0% |
| Q1 2019 | $963,000 | +28.9% | 54,816 | -5.8% | 0.00% | 0.0% |
| Q4 2018 | $747,000 | -21.2% | 58,184 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $948,000 | +391.2% | 58,184 | +242.4% | 0.00% | – |
| Q2 2018 | $193,000 | – | 16,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |